The strains have undergone antimicrobial activity for screening. Mainly strain D1 has shown good inhibition zone against Klebsiella and Proteus. Almost all strains have shown inhibition against Proteus and towards E. coli have shown less inhibition. It is observed that the new drugs, notably antibiotics, are urgently needed to halt and
64
reverse the relentless spread of antibiotic resistant pathogens which use to cause life threatening infections and risk which are undetermining with the viability of healthcare systems (Talbot et al., 2006).